Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Sarcoma 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Sarcoma 4Wilms Tumor 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Liver Neoplasms 2Kidney Neoplasms 2Astrocytoma 2Testicular Neoplasms 1Teratoma 1Sarcoma, Synovial 1Rhabdomyosarcoma 1Recurrent Uterine Corpus Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Optic Nerve Glioma 1Oligodendroglioma 1Medulloblastoma 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Eosinophilic, Acute 1Leukemia 1Head and Neck Neoplasms 1Gliosarcoma 1Glioblastoma 1Familial ependymoma 1Endometrial Adenocarcinoma 1Colonic Neoplasms 1

Interventions

Gemcitabine 5Cisplatin 5Oxaliplatin 4pembrolizumab 3Irinotecan 3Carboplatin 3Specimen Handling 2Radiosurgery 2Psychiatric Rehabilitation 2Observation 2Magnetic Resonance Spectroscopy 2Leucovorin 2Floxuridine 2Erlotinib Hydrochloride 2Cyclophosphamide 2Cetuximab 2Bortezomib 2Blood Specimen Collection 2trastuzumab deruxtecan 1tislelizumab 1spartalizumab 1sodium thiosulfate 1selpercatinib 1rucaparib 1repotrectinib 1pidilizumab 1pazopanib 1p53 peptide 264-272, human 1motexafin lutetium 1montanide ISA 51 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × ixabepilone × Sarcoma × Clear all
NCT01012362 2017-12-28

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
31 enrolled 12 charts
BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡